Keywords
cardiac CT - cardiac MRI - tuberculosis
Introduction
Pericardial and cardiac involvement by tuberculosis (TB), though uncommon, is the
second most common cause of TB-related deaths after cranial and spinal TB.[1] Tubercular involvement in the heart occur in the pericardium, myocardium, endocardium,
or coronary arteries.[2] The diagnosis of isolated pericardial and cardiac TB is difficult since the clinical
presentation is typically ambiguous, and traditional procedures, such as sputum smear
microscopy, culture, and histology, have limited sensitivity and specificity. As a
result, imaging techniques such as transthoracic echocardiography (TTE), cardiac computed
tomography (CT), and cardiac magnetic resonance (CMR) play a critical role in the
diagnosis, evaluation, its differentiation from other pathologies, in monitoring the
therapeutic response, and for follow-up of pericardial and cardiac TB. In this review
article, we will discuss the epidemiology, pathophysiology, clinical features, and
imaging modalities for evaluation of pericardial and cardiac TB, and we will review
the current evidence and recommendations on the use of echocardiography, cardiac CT,
and CMR imaging for the diagnosis and management of these conditions.
Epidemiology
TB is a prevailing infectious, communicable illness caused by Mycobacterium bacillus,
which is a significant cause of morbidity and mortality in the developing countries.
The World Health Organization statistics for India 2022 gave an incidence of 210 per
100,000 people.[3] Further, approximately 40% of Indians are thought to have Mycobacterium bacillus
infections, majority of whom have latent TB rather than an active illness.[4]
Pathophysiology
Mycobacterium bacillus is primarily a pulmonary pathogen but can affect all parts
of the body, including the heart and pericardium. These bacteria can reach the pericardium
and heart through:
-
Retrograde spread from hilar, peribronchial, subcarinal, and paratracheal lymph nodes
-
Direct spread from adjacent lungs and pleura
-
Hematogenous spread in miliary TB mainly in immunocompromised individuals who have
high TB bacilli load
Cardiovascular involvement in TB has been found to be associated with relatively poor
prognosis, like tubercular pericarditis has been found to be associated with mortality
as high as 40%[5] ([Table 1]).[6]
[7]
[8]
Table 1
Cardiac and pericardial involvement in tuberculosis[6]
Involvement type
|
Incidence
|
Pericardial involvement
|
2–5%[7]
|
Cardiac involvement
|
0.14–2%[8]
|
Pericardial Involvement in TB
Pericardial involvement is much more common than involvement of myocardial counterpart,
and shows variable presentation which includes:
-
Acute pericarditis with or without pericardial effusion
-
Acute pericarditis with underlying myocardial involvement: myopericarditis
-
Constrictive pericarditis (CP): Effusive type or chronic calcific/fibrotic type[9]
These types of pericardial involvements show frequent overlap with each other and
are not mutually exclusive. TB is a leading cause of chronic CP (CCP) in developing
countries and accounts for 38 to 83% of all cases.[10] Pericardial TB is relatively common among Cardiovascular System (CVS) involvement,
especially in immunocompromised individuals (acquired immunodeficiency syndrome) where
tubercular effusion in pericardium reaches as high as 85%.[5]
On the other hand, TB accounts for less than 5% of cases in immunocompetent persons
presenting with pericarditis[8] ([Table 1]). Ten percent of patients with TB-related pericarditis experience transient constriction,
and 20 to 50% of patients proceed to overt CCP even after receiving anti-TB treatment.[11] It is possible for CP to last for several years, before symptomatic heart failure
develops.[12]
Tuberculous pericarditis has four recognized pathological stages and different clinical presentation:
-
(1) Dry stage: This stage is characterized by fibrinous exudation, initial polymorphonuclear
leukocytosis, and loose macrophage and T cell organization. The patient clinically
presents with symptoms of acute pericarditis (chest discomfort, pericardial friction
rub, and broad ST elevation without effusion).
-
(2) Effusive stage: There is pericardial effusion with predominant cellular infiltrate
consisting of lymphocytes and monocytes; clinically, the patient presents with clinical
features of heart failure or cardiac tamponade. Moderate to massive pericardial effusion
is seen on imaging.
-
(3) Absorptive stage: There is pericardial fluid absorption and organization of exudates.
Caseating granuloma formation and pericardial thickening are seen on imaging and the
patient presents with clinical features of CP.
-
(4) Constrictive stage: In this stage, the clinical presentations and echocardiographic
findings are consistent with CP. However, no significant fluid is seen in the pericardial
cavity in this stage.
Imaging in Pericardial Tuberculosis
Imaging in Pericardial Tuberculosis
Echocardiography
TTE is first-line investigation of choice for pericardium evaluation owing to its
easy availability, high sensitivity and specificity index, no radiation exposure,
and relative cost effectiveness. TTE is routinely performed in suspected cases of
myopericardial TB, for the evaluation of pericardial thickening, myocardial function,
and structural and physiologic assessment ([Table 2]). However, TTE have limited diagnostic value in obese individuals, in patients with
poor acoustic window, and allows limited evaluation of pericardium anterior to right
ventricle (RV) and near atrioventricular (AV) groove, and is unable to identify localized
effusions and characterize myocardial tissue.
Table 2
Summary of European Association of Cardiovascular Imaging (EACVI) position paper on
recommendations in pericardial pathologies
|
|
Transthoracic echocardiography
|
Cardiac CT
|
Cardiac MR
|
Acute pericarditis
|
Noncomplicated
|
Recommended to confirm diagnosis
|
Not recommended
|
Recommended to confirm diagnosis
|
Complicated
|
Recommended to confirm diagnosis and plan pericardiocentesis
|
Not recommended
|
Reasonable for clinical diagnosis confirmation if echo inconclusive and f/u
|
Constrictive pericarditis (effusive type)
|
|
Recommended for clinical diagnosis confirmation and routine f/u
|
Reasonable for clinical diagnosis confirmation
|
Reasonable for clinical diagnosis confirmation, f/u, and assess myocardial involvement
|
Chronic constrictive pericarditis
|
|
Recommended for clinical diagnosis confirmation and routine f/u
|
Reasonable for clinical diagnosis confirmation and plan pericardiotomy.
|
Recommended for follow-up and to plan pericardiotomy.
Reasonable for clinical diagnosis confirmation if echo inconclusive.
Best investigation to differentiate it from RCMP which has similar picture on echocardiography
|
Abbreviations: CT, computed tomography; f/u, follow-up; MR, magnetic resonance; RCMP,
restrictive cardiomyopathy.
Echo Features of Constrictive Pericarditis
-
Pericardial thickening
-
Small tubular-shaped ventricles
-
Biatrial dilation and dilated systemic veins
-
Distorted ventricular septum (flattened/sigmoid)
-
Diastolic restriction of ventricles making it difficult to differentiate CP from restrictive
cardiomyopathy (RCMP)
-
Atypical septal movement (septal bounce)
Chest X-Ray
Chest X-rays are not a routine part of evaluation of pericardial pathologies. However,
they can provide an insight into the extracardiac focus of infection in lung parenchyma.
Pericardial calcifications usually seen in CCP are visible on chest X-ray in roughly
50% of cases.[10] Tubercular pericardial calcification occurs specifically in the AV and interventricular
grooves, as well as the inferior diaphragmatic surface of the pericardium that surrounds
the ventricles (region of normal fatty areas). TB has been associated with two distinct
pericardial calcification types: (1) linear and thin ([Fig. 1A, B]) which resembles eggshell calcification around the heart and was considered unique
to tuberculous CP or (2) it can appear thick and shaggy.[13]
Fig. 1 Chest X-ray posteroanterior (PA) (A) and lateral view (B) shows thin, circumferential, linear calcification in midpart of cardiac shadow along
atrioventricular groove in a patient of tubercular constrictive pericarditis.
CT Scan
CT is reasonable whenever there is suspicion of loculated collection or localized
pericardial thickening or TTE findings are nonconclusive for myopericardial TB[14] ([Table 2]). Further, attenuation values in CT can differentiate transudative (Hounsfield units
[HU] values similar to water) from exudative effusion (higher HU values).[15] Exudative effusion is more consistent with pericardial effusion secondary to TB.
Another benefit of doing cardiac CT is its great sensitivity in detecting calcification
in the pericardium ([Fig. 2]), which is usually seen in tubercular CP.
Fig. 2 Short-axis multiplanar (A), volume rendered (B,C), and four-chamber multiplanar (D). CT images show thickened and calcified pericardium along the atrioventricular (AV)
groove and inferior surface of the heart (black asterisk). In another patient, circumferential
pericardial calcification is seen (black asterisk) at the level of the AV groove and
basal ventricular myocardium in volume-rendered images (E,F).
Cardiac CT features favoring CP:
-
Thickened (> 4 mm), enhancing pericardium
-
Localized adherent thickened pericardium
-
Pericardial calcification is very sensitive and strongly suggestive of tubercular
etiology (lung, lymph node calcification)
-
Biatrial dilation with dilated systemic and hepatic veins (HVs)
-
Retrograde flow of contrast into inferior vena cava and HVs
-
Tubular configuration of ventricles
-
Septal bounce on retrospectively gated CT scan helps distinguish it from RCMP
-
Better evaluation of mediastinal lymph nodes and lung parenchyma to look for extracardiac
focus of tubercular infection
-
Associated pericardial or pleural effusion
But because of the risk of radiation exposure, poor contrast resolution, limitation
of CT in differentiating a small effusion from pericardial thickening,[13] and better CMR availability, CMR is preferred for evaluation of pericardial pathologies.
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is the gold standard imaging modality for evaluating
various pericardial diseases ([Table 2]). Its advantages include no radiation exposure, noninvasiveness, multiplanar imaging,
potential for tissue characterization, large field of view, best depiction of pericardial
thickness, and ability to differentiate small pericardial effusion from thickened
pericardium. Disadvantages of CMR include its difficulty in identifying calcifications
and the need for electrocardiogram gating (difficult to perform in patients with atrial/ventricular
tachyarrhythmias).
Normal pericardium show linear hypointense signal on T1- and T2-weighted images around
cardiac chamber with pericardial thickness ≤ 4 mm in normal individuals.
(1) Acute pericarditis: Cardiac MR is a gold standard imaging modality for assessment
of pericardial inflammation and for therapeutic response monitoring.[16] CMR in acute pericarditis reveals thickened pericardium (> 4 mm), pericardial effusion,
and can diagnose pericardial layer edema. T1 and T2 mapping values are being recently
utilized to characterize pericardial effusion and assess pericardial inflammation.
T1 values are significantly found to be lower in exudative pericardial effusion and
a cutoff T1 value of 3013 millisecond is found to differentiate transudates from exudates
acquired at 1.5T MRI[17] with a sensitivity of 94% and specificity of 79%.[18]
T1 values in inflamed pericardium are typically elevated, reflecting the presence
of increased extracellular water and inflammatory cells. It has been reported that
native T1 values > 1,730 millisecond had a sensitivity of 94% and specificity of 71%
to diagnose moderate or greater pericardial delayed enhancement and can be used as
a contrast-independent marker for detecting pericardial inflammation.[19]
A suitable method for identifying pericardial inflammation is pericardial enhancement,
on gadolinium-enhanced CMR with fat-water late gadolinium enhancement (LGE) making
pericardial inflammation more visible ([Fig. 3]). Other imaging features include linear enhancement of the surrounding fat and adjacent
cardiac tissue, which indicates simultaneous myocardial involvement. Pericardial enhancement
become more irregular in chronic pericarditis.[16]
Fig. 3 CMR revealed global thickening of the pericardium (A,B) with diffuse pericardial enhancement (F) and biatrial dilatation with tubular configuration of ventricles (A). Peripherally enhancing collection (F-H) showing elevated native T1 mapping values (approximately 1,600 msec in (E) is also seen along the epicardial surface of the left ventricle and left atrium.
(2) CCP: CCP is characterized by a thickened, fibrotic, rigid, and adherent pericardium
which restricts diastolic filling and lead to diastolic dysfunction of ventricles
and potential symptoms of right heart failure. MRI has a reported accuracy of 93%
for differentiation between CP and RCMP on the basis of depiction of thickened pericardium
(> 4 mm). The differentiation of CCP from RCMP is of utmost importance as CCP is managed
by surgery and is usually curable whereas RCMP is treated medically and eventually
require heart transplant. It is important to remember, however, that neither pericardial
thickening nor calcification is diagnostic of CP unless the patient also has symptoms
of physiologic constriction or restriction.
Tuberculous pericarditis causes pericardial thickness to vary in many areas (1–17 mm;
mean, 4 mm) in patients with constrictive physiology (96%). However, it has been reported
that up to 18 to 20% of patients with CP have a normal pericardial thickness.[20]
[21]
Furthermore, CMR tagging techniques may be useful for accurately depicting fibrotic
pericardial adhesions. Tag lines are usually displaced during the cardiac cycle in
healthy people due to the pericardium's unrestricted mobility; however, in individuals
with pericardial adhesions, these lines fail to break and appear stretched due to
adhesion between pericardial layers. No pericardial enhancement is seen in fibrotic
end stage of CP ([Table 3]).
Table 3
Multimodal imaging evaluation of tubercular pericarditis stages[23]
|
Echocardiography
|
CT
|
MRI
|
Pericardial thickening
|
++
|
+
|
++
|
Pericardial enhancement
|
−
|
+
|
++
|
Pericardial effusion
|
++
|
+
|
++
|
Myocardial involvement
|
−
|
−
|
++
|
Pericardial calcification
|
−
|
++
|
–
|
Functional evaluation
|
+
|
−
|
++
|
Abbreviations: CT, computed tomography; MR, magnetic resonance imaging.
Typical CMR features of CP include ([Fig. 4]):
-
Morphological: thickened pericardium (> 4 mm[22])
-
Better differentiation of pericardial fluid from pericardial thickening
-
Functional changes–cine MRI: septal flattening/septal bounce on 4 chamber and short
axis cine images
-
Respiratory changes: on free deep breathing MR, accentuation of septal bounce is seen
on inspiration with reversal of septal bounce on expiration
-
Right atrium (RA) and left atrium (LA) dilatation
-
If a good fat plane is seen between the pericardium and myocardium, an easier dissection
during the surgery can be predicted
-
Tagging sequences: shows no distortion of grid lines at myopericardial interface suggestive
of adhesion
-
Myocardial evaluation: myocardial atrophy/fibrosis, which carries a poorer prognosis
even after pericardial resection
Fig. 4 CMR revealed enhancing (G,H), global thickening of the pericardium (A,B) with elevated native T2 mapping values (approximately 59 msec in C). In addition,
tubular configuration of both ventricles with biatrial dilation is also seen (B-D). On tagging sequences, the grid lines are maintained along the borders of the ventricle
with the pericardium, suggesting adhesion (E,F) and are consistent with findings of chronic constrictive pericarditis with pericardial
adhesion.
Disadvantage: Inability to identify pericardial calcification ([Table 3])[23]
Myocardial Involvement
First case of myocardial TB was reported by Maurocordat on autopsy in 1664.[16] Myocardial involvement in TB is rare, documented in up to 0.3% of individuals dying
due to tuberculsosis,[24] often not diagnosed while they are alive.[25] The tuberculous myocarditis cases were predominantly seen with concomitant pulmonary
infection (56%) and concomitant pericarditis (43%).[1]
Myocardial Tubercular Involvement[26]
-
Miliary tubercles of the heart, which are common in miliary TB patients, with the heart being one of several organs
affected.[1]
-
Myocardial tuberculoma: Tuberculoma in heart varies from pea to egg size, with central caseation. They can
involve atria, ventricles, and interventricular septum.[10]
-
Diffuse infiltrative type: Least common.
Spread
Myocardial involvement in TB can happen by:
-
Hematogenous spread from an extracardiac focus,
-
Direct spread from the adjacent lung or pericardium, or
-
Retrograde lymphatic spread from mediastinal lymph nodes.
Clinical Presentation
Myocardial tuberculomas are associated with infiltration of all myocardial layers
and have variable presentation, and can remain asymptomatic or present as[27]:
-
Cardiac conduction abnormalities: Heart block, bradyarrhythmias, or tachyarrhythmias
-
Congestive heart failure
-
Acute fulminant myocarditis
-
Sudden cardiac death
-
Ventricular pseudoaneurysm, RV outflow obstruction, and coronaries involvement
-
Atrial and ventricular arrhythmia
-
Superior vena caval obstruction
-
Long QT syndrome
-
High-grade heart block
Imaging in Tubercular Myocarditis
TB is a rare cause of myocarditis which carries high mortality rate. TB myocarditis
carries a low incidence rate, gradual onset, and slow progression[28] and is diagnosed mostly in postmortem study. Isolated cases of tuberculous myocarditis
without involvement of any other organs are very rare with few case reports reported
in literature. Tubercular myocarditis is uncommon, with reported rates of less than
2% in various case series, most of them being in immunocompromised individuals.[29]
Tuberculous myocarditis is mainly reported in “young” (< 45 years) individuals and
males are more commonly affected than females (2:1).[30] Tubercular myocarditis involves most commonly the left ventricle (LV) (68%), followed
by the RV (43%), RA (37%), and least LA involvement seen in 18% of the cases.[29]
In acute phase, LV myocardium may appear hypertrophied and shows signal intensity,
mapping values of myocarditis, that is, isointense to hypointense on T1- and hyperintense
on T2-weighted sequences with elevated native T1 and T2 mapping values, and areas
of LGE similar to CMR findings seen in other myocarditis. If cardiac TB is suspected,
imaging of the thorax, head, and abdomen may indicate a primary focus, as the majority
of myocardial TB cases are caused by dissemination from an extracardiac focus. Once
detected, cardiac TB responds quite effectively to regular anti-TB treatment.[31]
Cardiac Tuberculoma
Myocardial tuberculomas are mass-like lesions in the heart. They are extremely rare
and were found in just 19 of 13,658 postmortem cases (0.14%)[30] in an autopsy study. They commonly involve the right-sided chamber of the heart,
namely, the RA wall, because of frequent involvement of the right-sided mediastinal
lymph nodes or secondary to contiguous spread.
Echocardiography
TTE can accurately detect the mass, its location, and its hemodynamic impact and may
reveal a hypoechoic or echogenic (calcified tuberculoma) immovable mass in the ventricular
myocardium or atrial wall.
Cardiac MRI
TTE, being the first-line imaging modality, lacks specificity, and cardiac MR is the
way to go for myocardial mass evaluation. Cardiac MRI provides additional advantage
to TTE as it provides:
-
Better mass characterization
-
Precise location of the mass
-
Relationship to the cardiac chambers
-
Extension to the pericardium and surrounding mediastinal structures
-
Differentiate it from other cardiac masses
Typical MRI features of cardiac tuberculomas include:
-
Well-circumscribed, sharply demarcated mass from the surrounding myocardium/atrial
wall[32]
-
Iso to hypo on T1- and T2-weighted images. Shortening of T2 can differentiate tuberculoma
from other myocardial mass like secondary metastases or primary angiosarcoma, which
appear bright on T2-weighted images
-
Classic appearance of myocardial tuberculoma is seen on T2-weighted images, that is,
they typically show a central isointense core surrounded by hypointense rim and an
outer thin hyperintense line. Central core correspond to caseation which are surrounded
by fibrous capsule and outer infiltration by inflammatory cells
-
Post Gadolinium images: Variable enhancement is seen in post-Gd images ranging from
heterogeneous LGE to ring enhancement around a central nonenhancing core with conglomeration
at the periphery.
But these characteristic features of myocardial tuberculomas are rarely seen owing
to rarity of disease and it can act as great masquerader of other cardiac mass.[1] In such cases, extracardiac focus of tuberculous infection may give a hint to the
diagnosis. The treatment of myocardial tuberculomas primarily involves administration
of antitubercular therapy (ATT) regimen. It has been reported that complete clinical
and imaging disappearance of mass occurs after ATT initiation[33] ([Figs. 5] and [6]). MRI can be used for follow-up of these tuberculomas after treatment.
Fig. 5 CMR revealed a broad based RA-RV mass extending into the pericardial space (A-C) and encasing the right coronary artery (RCA) (D). The mass is hyperintense on short tau inversion recovery (STIR) (C), isointense on T1-wighted image (T1WI) (B) with diffusely elevated native T1, T2 mapping values in mass (E, F) and shows heterogeneous enhancement (G,H). Further excisional biopsy gave diagnosis of tuberculoma on histopathology.
Fig. 6 After 1 year of antitubercular therapy, complete resolution of mass is seen (A,B) with linear late gadolinium enhancement (black arrow) along the free wall of right
ventricle (RV) (C,D).
Papillary Muscle Involvement
Papillary muscle enlargement is a rare cardiovascular manifestation secondary to tubercular
involvement which is rarely seen in clinical practice and is often an autopsy finding.[16]
Coronary Artery Disease
Studies have shown a higher association (1.75 to 2 times) of acute myocardial infarction
as well as coronary atherosclerosis in TB patients in developing countries.[2] Several mechanisms are postulated behind this like:
-
Latent TB infection causes chronic inflammation and cell-mediated injuries of coronaries,
eventually leading to coronary artery disease.
-
Immunological response to heat shock protein-65 (HSP65) from mycobacteria with resultant
cross-reaction with human HSP65, which damages endothelium and promotes atherogenesis
in coronaries.[2]
Conclusion
Pericardial and cardiac involvement in TB is an uncommon extrapulmonary manifestation
of TB that can result in variable presentation ranging from heart failure, CP, or
sudden cardiac death. Hence, early diagnosis of this form of extrapulmonary TB is
critical to overall care. Although TTE is the screening modality for identifying pericardial
and myocardial involvement in TB, advanced imaging modalities like cardiac CT and
CMR give greater tissue characterization, which are usually necessary to help diagnose
and differentiate it from the lesions mimicking them. Early diagnosis of cardiac TB,
be it pericardial or myocardial, can help direct early institution of ATT besides
deciding for and against surgical interventions in these patients. MRI remains the
imaging tool of choice for deciding management and follow-up of these patients.